Neurol. praxi. 2010;11(4):265-270

Anxiety disorders in neurology

doc.MUDr.Ján Praško, CSc.1,2,3,4, MUDr.Pavel Doubek1, MUDr.Tomáš Diveky1,2, MUDr.Aleš Grambal1,2, MUDr.Zuzana Grambalová2,8, MUDr.Erik Herman, Ph.D.6, doc.MUDr.Jiří Hovorka, CSc.7, MUDr.Dana Kamarádová1,2, MUDr.Andrea Kovaczová1,2, MUDr.Klára Látalová, Ph.D.1,2, MUDr.Petr Šilhán9
1 Klinika psychiatrie Fakultní nemocnice Olomouc
2 Lékařská fakulta Univerzity Palackého v Olomouci
3 Centrum neuropsychiatrických studií, Praha
4 Psychiatrické centrum Praha
5 Psychiatrická klinika 1. lékařská fakulta Univerzity Karlovy, Praha
6 Psychiatrická ambulance, Praha
7 Neurologické oddělení Na Františku, Praha
8 Klinika neurologie Fakultní nemocnice Olomouc
9 Psychiatrické oddělení, Fakultní nemocnice v Ostravě

Anxiety disorders commonly occur in neurologic conditions, and the relationships they have with such conditions are of particular interest,

pointing in some instances to the involvement of certain brain regions or circuits. Neurological illnesses in comorbidity with anxiety

disorders are associated with greater functional impairment, increased utilization of health services, and less favorable outcome. The

manifestations and comorbidities of various neurological illnesses routinely involve psychiatric diagnosis and management.

Keywords: neurological illnesses, anxiety disorders, diagnosis, comorbidity, treatment

Published: October 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Praško J, Doubek P, Diveky T, Grambal A, Grambalová Z, Herman E, et al.. Anxiety disorders in neurology. Neurol. praxi. 2010;11(4):265-270.
Download citation

References

  1. Allen LA, Gara MA, Escobar L, Waitzkin H, Silver RC. Somatization. Psychosomatics 2001; 42: 63-67. Go to original source... Go to PubMed...
  2. Aström M. Generalized anxiety disorder in stroke patients: a 3year longitudinal study. Stroke 1996; 27: 270-275. Go to original source... Go to PubMed...
  3. Baider L, Peretz R, Hadani PE, Perry S, Avramov R, De-Nour AK. Transmission of response to trauma? Second-generation Holocaust survivors´ reaction to cancer. Am J Psychiatry 2000; 157: 904-910. Go to original source... Go to PubMed...
  4. Castillo CS, Starkstein SE, Fedoroff JP, Price TR, Robinson RG. Generalized anxiety disorder following stroke. J Nerv Ment Dis 1993; 181: 100-106. Go to original source... Go to PubMed...
  5. Doubek P, Roth J, Židovská J, Uhrová T. Diagnostika a léčba psychiatrické symptomatiky u pacientky s Huntingtonovu nemocí. Psychiat. pro praxi, 2002: pp. 129-131.
  6. Fawzy FI, Canada AL, Fawzy NW. Effects of a brief, structured psychiatric intervention on survival and recurrence at 10year follow-up. Arch Gen Psychiatry 2003; 60: 100-103. Go to original source... Go to PubMed...
  7. Feinstein A. The neuropsychiatry of multiple sclerosis. Can J Psychiatry 2004; 49: 157-163. Go to original source... Go to PubMed...
  8. George MS, Trimble MR, Ring HA, Sallee FR, Robertson MM. Obsessions in obsessive-compulsive disorder with and without Gilles de la Tourette's syndrome. Am J Psychiatry. 1993; 150(1): 93-97. Go to original source... Go to PubMed...
  9. Herman E a Hovorka J. Diagnostika a léčba psychických poruch v neurologii. Konsiliární psychiatrie. Medical Tribune 2007; 378-392.
  10. Hibbard MR, Uysal S, Kepler K, Bogdany J, Silver J. Axis I psychopathology in individuals with traumatic brain injury. J Head Trauma Rehab 1998; 13: 24-39. Go to original source... Go to PubMed...
  11. Janke E, Holroyd K, Romanek K. Depression increases onset oftension-type headache following laboratory stress. Pain 2004; 111: 230-238. Go to original source... Go to PubMed...
  12. Juang KD, Wang SJ, Fuh JL, Lu SR, Su TP. Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache 2000; 40: 818-823. Go to original source... Go to PubMed...
  13. Kimura M, Robinson RG. Treatment of poststroke generalized anxiety disorder comorbid with poststroke depression. Merged analysis of nortriptyline trials. Am J Geriatr Psychiatry 2003; 11(3): 320-327. Go to original source...
  14. Ling MH, Perry PJ, Tsuang MT. Side effects of corticosteroid therapy: psychiatric aspects. Arch Gen Psychiatry 1981; 38: 471-477. Go to original source... Go to PubMed...
  15. Lloyd KR, Jenkins R, Mann A. Long-term outcome of patients with neurotic illness in medical practice. BMJ 1996; 313: 26-28. Go to original source... Go to PubMed...
  16. Mayou RA, Bryant B, Duthie R. Psychiatric consequences of road traffic accidents. Br Med J 1993; 307: 647-651. Go to original source... Go to PubMed...
  17. Mayou RA, Hawton K, Feldman E. What happens to medical patients with psychiatric disorders? J Psychosom Res 1988; 32: 541-549. Go to original source... Go to PubMed...
  18. Mayou RA, Gill D, Thompson DR, Day A, Hicks N, Volmink J, Neil A. Depression and anxiety as predictors of outcome after myocardial infarction. Psychosom Med 2000; 62: 212-219. Go to original source... Go to PubMed...
  19. Merikangas KR, Stevens DJ, Merikangas JR. Migraine and other headache disorders. In: Robinson RG, Yates WR eds. Psychiatric Treatment of the Medically Ill. New York, NY: Marcel Dekker; 1999: 425-442.
  20. Mezinárodní klasifikace nemocí. 10. revize. Duševní poruchy a poruchy chování: Diagnostická kritéria pro výzkum. (přeloženo z anglického originálu) Praha, Psychiatrické centrum 1996; Zprávy č. 134.
  21. Miguel EC, Baer L, Coffey BJ, Rauch SL, Savage CR, O'Sullivan RL, Phillips K, Moretti C, Leckman JF, Jenike MA. Phenomenological differences appearing with repetitive behaviours in obsessive-compulsive disorder and Gilles de la Tourette's syndrome. Br J Psychiatry 1997; 170: 140-145. Go to original source... Go to PubMed...
  22. Noyes R, Holt CS, Massie MJ. Anxiety disorders. In: Holland JC (ed): Psycho-oncology. Oxford University Press, New York 1998: 548-563.
  23. Pašková B, Praško J, Horáček J, Záleský R, Kopeček M, Škrdlantová L, Bělohlávek O. Identifikace souvislosti vychytávání 18FDG PET s mírou symptomatologie u panické poruchy. Psychiatrie 2003; 7(Suppl. 3): 6-9.
  24. Pedersen SS. Post-traumatic stress disorder in patients with coronary artery disease: a review and evaluation of the risk. Scand J Psychol 2001; 42: 445-451. Go to original source... Go to PubMed...
  25. Petter T, Richter MA, Sandor P. Clinical features distinguishing patients with Tourette's syndrome and obsessive-compulsive disorder from patients with obsessive-compulsive disorder without tics. J Clin Psychiatry 1998; 59(9): 456-459. Go to original source... Go to PubMed...
  26. Praško J, Horáček J, Záleský R, Kopecek M, Novák T, Pasková B, Skrdlantová L, Belohlávek O, Höschl C. The change of regional brain metabolism (18FDG PET) in panic disorder during the treatment with cognitive behavioral therapy or antidepressants Neuroendocrinological Letters 2005; 25: 340-348.
  27. Praško J. Úzkostné poruchy. Klasifikace, diagnostika a léčba. Portal, Praha 2005.
  28. Praško J. Úzkostné poruchy v konsiliární psychiatrii. In: Herman E, Praško J, Seifertová D. Konsiliární psychiatrie. Medical Tribune 2007: 94-106.
  29. Reynolds DJ, Hovanitz CA. Life events stress and headache frequency revisited. Headache 2000; 40: 111-118. Go to original source... Go to PubMed...
  30. Rickels K, Schweizer EE. Current pharmacotherapy of anxiety and panic. In: Meltzer HY, ed. Psychopharmacology: The Third Generation of Progress. New York, NY: Raven Press; 1987: 1193-1203.
  31. Shiba M, Bower JH, Maraganore DM, McDonnell SK, Peterson BJ, Ahlskog JE, Schaid DJ, Rocca WA. Anxiety disorders and depressive disorders preceding Parkinson's disease: a casecontrol study. Mov Disord 2000; 15: 669-677. Go to original source... Go to PubMed...
  32. Starkstein SE, Cohen BS, Fedoroff P, Parikh RM, Price TR, Robinson RG. Relationship between anxiety disorders and depressive disorders in patients with cerebrovascular injury. Arch Gen Psychiatry 1990; 47: 785-789. Go to original source... Go to PubMed...
  33. Stein MB, Heuser IJ, Juncos JL, Uhde TW. Anxiety disorders in patients with Parkinson's disease. Am J Psychiatry 1990; 147: 217-220. Go to original source... Go to PubMed...
  34. Stiefel FC, Breitbart WS, Holland JC. Corticosteroids in cancer: neuropsychiatric complications. Cancer Invest 1989; 7: 479-491. Go to original source... Go to PubMed...
  35. Torta R, Keller R. Behavioral, psychotic, and anxiety disorders in epilepsy: etiology, clinical features, and therapeutic implications. Epilepsia 1999; 40(suppl 10): S2-S20. Go to original source... Go to PubMed...
  36. van Reekum R, Cohen T, Wong J. Can traumatic brain injury cause psychiatric disorders? N Neuropsychiatry Clin Neurosci 2000; 12: 316-327. Go to original source...
  37. Venable V, Carlson C, Wilson J. The role of anger and depression in recurrent headache. Headache 2001; 41: 21-30. Go to original source... Go to PubMed...
  38. Walsh K, Bennett G. Parkinson's disease and anxiety. Postgrad Med 2001; 77: 89-93. Go to original source... Go to PubMed...
  39. Weisskopf MG, Chen H, Schwarzschild MA, Kawachi I, Ascherio A. Prospective study of phobic anxiety and risk of Parkinson's disease. Mov Disord 2003; 18: 646-651. Go to original source... Go to PubMed...
  40. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lépine JP, Newman SC, Oakley-Browne MA, Rubio-Stipec M, Wells JE, Wickramaratne PJ, Wittchen HU, Yeh EK. The crossnational epidemiology of panic disorder. Arch Gen Psychiatr 1997; 54: 305-309. Go to original source... Go to PubMed...
  41. Wells KB, Golding JM, Burham MA. Psychiatric disorders in a sample of general population with a without medical conditions. Am J Psychiatry 1998; 52: 100-113.
  42. Zorzon M, de Masi R, Nasuelli D, Ukmar M, Mucelli RP, Cazzato G, Bratina A, Zivadinov R. Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 studies. J Neurol 2001; 248: 416-421. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.